4-Chlorophenylalanine-2-amino-3-(4-chlorophenyl)propanoic acid.

4-Chlorophenylalanine-2-amino-3-(4-chlorophenyl)propanoic acid, also known as CPAC, is an amino acid derivative that has shown potential therapeutic applications in the treatment of certain neurological disorders, particularly in the modulation of dopamine and serotonin neurotransmission. The chemical structure of CPAC includes a phenylalanine residue, which is a precursor to tyrosine and subsequently dopamine, and a 4-chlorophenyl group which provides additional pharmacological activity. CPAC has been found to inhibit the activity of the enzyme monoamine oxidase (MAO), which is responsible for breaking down neurotransmitters such as dopamine and serotonin. Inhibition of MAO leads to increased levels of these neurotransmitters in the brain, which can have a positive effect on mood and behavior. CPAC has also been shown to have anticonvulsant properties, making it a potential treatment for epilepsy. In terms of usage, CPAC is typically administered orally in the form of a tablet or capsule. Dosages can vary depending on the specific application, but typically range from 100-500 mg per day. As with any medication, it is important to follow the prescribed dosage and consult with a healthcare professional before use. In summary, CPAC is a promising amino acid derivative with potential therapeutic applications in the treatment of neurological disorders. Its ability to modulate neurotransmitter levels in the brain, coupled with its anticonvulsant properties, make it a valuable tool in the fight against these debilitating conditions.